close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Cumberland Pharmaceuticals Inc. - Common Stock (NQ:CPIX)

6.540 +1.240 (+23.40%)
Delayed Quote Updated: 1:05 PM EST, Nov 11, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Cumberland Pharmaceuticals Inc. - Common Stock

< Previous 1 2 3 4 Next >
News headline image
Cumberland Pharmaceuticals Q3 Earnings Call Highlights ↗
Cumberland Pharmaceuticals (NASDAQ:CPIX) reported third-quarter net income of $77.8 million, reflecting the sale of its commercial products to Apotex Health, and outlined plans to advance its lead drug... 
Via MarketBeat
Topics Earnings
News headline image
Levi & Korsinsky Notifies Investors of Pending Investigation Into Securities Claims Involving Cumberland Pharmaceuticals (CPIX)
From Levi &amp; Korsinsky, LLP
Via ACCESS Newswire
News headline image
CPIX Investors Have Opportunity to Join Cumberland Pharmaceuticals Inc. Fraud Investigation with SBS Law
From Schall, Brown & Schwartz LLP
Via Business Wire
News headline image
Cumberland Pharmaceuticals Begins Rolling FDA NDA for Dyscorban in Duchenne Cardiomyopathy ↗
Cumberland Pharmaceuticals (NASDAQ:CPIX) said it plans to begin a rolling New Drug Application submission for Dyscorban, its ifetroban candidate for cardiomyopathy associated with Duchenne muscular... 
Via MarketBeat
News headline image
Earnings Scheduled For November 4, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For August 5, 2025 ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 6, 2025 ↗
 
Via Benzinga
News headline image
Cumberland Pharmaceuticals Q2 Earnings Call Highlights ↗
Cumberland Pharmaceuticals (NASDAQ:CPIX) reported a second-quarter operating loss of $3.1 million as it prepared to transition from a commercial-stage specialty pharmaceutical company into an... 
Via MarketBeat
Topics Earnings
What's going on in today's pre-market session ↗
Via Chartmill
News headline image
Cumberland (CPIX) Q4 2025 Earnings Call Transcript ↗
Cumberland (CPIX) Q4 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
CPIX Stock Earnings: Cumberland Reported Results for Q1 2024 ↗
Cumberland just reported results for the first quarter of 2024. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Cumberland (CPIX) Q2 Revenue Up 10% ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Earnings Scheduled For March 4, 2025 ↗
 
Via Benzinga
News headline image
Top movers analysis one hour before the close of the markets on 2025-02-19: top gainers and losers in today's session. ↗
Keep an eye on the top gainers and losers in Wednesday's session, as they reflect the most notable price movements. 
Via Chartmill
News headline image
Here are the top movers in Wednesday's session. ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
What's going on in today's session ↗
Here are the top movers in Wednesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
News headline image
What's going on in today's after hours session ↗
The regular session of the US market on Tuesday is now over, but let's get a preview of the after-hours session and explore the top gainers and losers driving the post-market movements. 
Via Chartmill
News headline image
Top movers analysis one hour before the close of the markets on 2025-02-04: top gainers and losers in today's session. ↗
Curious about what's happening in today's session? Check out the latest stock movements and price changes. 
Via Chartmill
News headline image
Cumberland Pharmaceuticals' Duchenne Candidate Shows Improved Heart Function In Patients With Associated Heart Disease ↗
Cumberland Pharmaceuticals' Phase 2 trial shows ifetroban improves heart function in Duchenne muscular dystrophy patients. 
Via Benzinga
News headline image
Discover the top movers in Tuesday's pre-market session. ↗
Before the US market kicks off on Tuesday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
News headline image
S&P 500 Edges Lower; AutoZone Posts Downbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
Gold Gains Over 1%; Ollie's Bargain Outlet Shares Jump After Q3 Earnings ↗
 
Via Benzinga
News headline image
Why Is Cumberland Pharmaceuticals Stock Trading Over 100% on Tuesday? ↗
FDA approval streamlines Acetadote dosing, enhancing safety and efficiency in treating acetaminophen-related liver injury in hospitals worldwide. 
Via Benzinga
News headline image
Dow Falls 150 Points; Oracle Posts Downbeat Results ↗
 
Via Benzinga
Topics Stocks
News headline image
Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
< Previous 1 2 3 4 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at /week.